A novel colonic drug delivery system of ibuprofen

Asian Journal of Pharmaceutics

Volumn 3, Issue 3, 2009, Pages 233-239

  Gohel, M C ^a   Nagori, S A ^a  

^a GUJARAT UNIVERSITY   (India)

Author keywords

Ethyl cellulose; Eudragit S100 and capsule within capsule; Eutectic mixture; Ibuprofen; Menthol

Indexed keywords

ETHYL CELLULOSE; EUDRAGIT; HYDROXYPROPYLMETHYLCELLULOSE; IBUPROFEN; MENTHOL; STARCH;

ARTICLE; CONTROLLED STUDY; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; INTESTINE; SCANNING ELECTRON MICROSCOPY; STOMACH PH;

EID: 77953465946     PISSN: 09738398     EISSN: 1998409X     Source Type: Journal    
DOI: 10.4103/0973-8398.56304     Document Type: Article

References (37)

1. Barbara L, Teresa C, Federica B, Isabella O, Vittorio Z. pH-sensitive polymeric physical-mixture for possible site-specific delivery of ibuprofen. Eur J Pharm Biopharm 2003;55:199-202.
2. Antonin K, Rak R, Beick P, Schenker U, Hastewell J, Fox R, et al. The absorption of human calcitonin from the transverse colon of man. Int J Pharm 1996;130:33-39
3. Tozaki H, Komoike J, Tada C, Marnyama T, Terabe A, Suzuki T, et al. Chitosan capsules for colon-specific drug delivery: Improvement of insulin absorption from the rat colon. J Pharm Sci 1997;86:1016-1021
4. Van-den M, Kinget R. Oral colon-specific drug delivery: A review. Drug Delivery 1995;2:81-93.
5. Rama Prasad Y, Krishnaiah Y, Satyanarayana S. in vitro evaluation of guar gum as a carrier for colon-specific drug delivery. J Control Rel 1998;51:281-287
6. Evans D, Pye G, Bramely R, Clark A, Dysoa T. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 1988;29:1035-1041
7. Ashford M, Fell J, Attwood D, Sharma H, Woodhead P. An in vivo investigation into the suitability of pH dependent polymers for colonic targeting. Int J Pharm 1993;95:193-199 (Pubitemid 23203152)
8. Davis S, Hardy J, Taylor M, Stockwell A, Whalley D, Wilson C. The in vivo evaluation of an osmotic device (Osmet) using gamma scintigraphy. J Pharm Pharmacol 1984;36:740-742
9. Marvola M, Aito H, Ponto P, Kanniksoki A, Nykanen S, Kokkonen P. Gastrointestinal transit and concomitant absorption of verapamil from a single unit sustained release tablet. Drug Dev Ind Pharm 1987;13:1593-1609
10. Vyas S, Khar R. Controlled Drug Delivery-Concepts and Advances. New Delhi: Vallabh Prakashan; 2002. p. 218-256
11. Brondsted H, Andersen C, Hovgaard L. Crosslinked dextran-A new capsule material for colon targeting of drugs. J Control Rel 1998;53:7-13.
12. Huskisson E. Anti-Rheumatic Drugs. Westport: Praeger Publishers Inc; 1983. p. 244-266
13. Wilson C, Washington N, Greaves J, Kamali F, Rees J, Sempik A, et al. Bimodal release of ibuprofen in a sustained release formulation: A scintigraphic and pharmacokinetic open study in healthy volunteers under different conditions of food intake. Int J Pharm 1989;50:155-161
14. Yao M, Zhou W, Sangha S, Albert A, Chang AJ, Liu TC, et al. Effects of nonselective cyclooxygenase inhibition with low-dose ibuprofen on tumor growth, angiogenesis, metastasis, and survival in a mouse model of colorectal cancer. Clin Cancer Res 2005;11:1618-1628
15. Gohel M, Parikh R, Nagori S, Dabhi M. Design of potential colonic drug delivery system of mesalamine. Pharm Dev Tech 2008;13:447-456
16. Singh BN. Modified-release solid formulations for colonic delivery. Recent Pat Drug Deliv Formul 2007;1:53-63.
17. Mariko M, Ayako M, Kozo T, Koichi I, Tsuneji N. Improving insulin enteral absorption using water-in-oil-in water emulsion. Int J Pharm 1998;172:189-198
18. Flashner-Barak M, Lerner I, Rosenberger V, Moldavski N. Menthol solutions of drugs. Patent WO/2004/073686 Sep 2, 2004.
19. Mckay D, Blumberg J. A review of the bioactivity and potential health benefits of peppermint tea (Mentha piperita L.). Phytother Res 2006;20:619-633 (Pubitemid 44238425)
20. Nahor H, Chell N, Kamyar H, Carlos K, Osvaldo C, Jenna R, et al. A multi- scale stochastic drug release model for polymer-coated targeted drug delivery systems. J Control Rel 2006;110:314-322
21. François L, Louis C, Roch T. New methods characterizing avalanche behavior to determine powder flow. Pharm Res 2002;19:887-893
22. United States Pharmacopoeia, 2006, Asian edition. United States Pharmacopoeial Convention Inc: 1842.
23. Indian Pharmacopoeia. Vol.1. 1996. p. 736.
24. Sangalli M, Maroni A, Foppoli A, Zema L, Giordano F, Gazzaniga A. Different HPMC viscosity grades as coating agents for an oral time and/or site-controlled delivery system: A study on process parameters and in vitro performances. Eur J Pharm Sci 2004;22:469-476
25. British Pharmacopoeia. Vol.2. 2001. Appendix XII B.
26. Pawar A, Paradkar, Kadam S, Mahadik K. Agglomeration of ibuprofen with talc by novel crystallo-co-agglomeration technique. AAPS Pharm Sci Tech 2004;5:e55.
27. Garekani H, Sadeghi F, Badiee A, Mostafa S, Ali R, Rajabi Siahboomi A. Crystal habit modifications of ibuprofen and their physicomechanical characteristics. Drug Dev Ind Pharm 2001;27:803-809
28. Bunyan J, Shankland N, Sheen D. Solvent effects on the morphology of ibuprofen. AIChe Symp Ser 1991;87:44-57.
29. Gordon R, Amin S. Crystallization of ibuprofen. U. S. Patent 44, 76, 248 Oct 9, 1984.
30. Franz R. Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing. U. S. Patent 46, 09, 675 Sep 2, 1986.
31. Chen J. Process for enhancing the flow characteristics of ibuprofen. U. S. Patent 5,191,114 March 2, 1993.
32. Groenewoud P, Facemire J, Jayanth J. Narcotic composition and method for making same. Patent WO 2005/037192 April 28, 2005.
33. Raymond R, Paul S. Handbook of Pharmaceutical Excipients. 4th ed. London: The Pharmaceutical Press; 1994. p. 373-377, 462-8, 609-11.
34. Vasanthakumar S, Vijaya R. Immediate release tablets of telmisartan using superdisintegrant-formulation, evaluation and stability studies. Chem Pharm Bull 2008;56:575-577
35. Inactive Ingredient Guide (Redacted). U.S. Food and Drug Administration, Center for Drug Evaluation and Research. January, 1996; Available from: http://www.fda.gov/cder/drug/iig/default.htm. [last accessed on 2006 Jun 18].
36. Meza C, Santos M, Romañach R. Quantitation of drug content in a low dosage formulation by transmission near infrared spectroscopy. AAPS Pharm Sci tech 2006;7:E29.
37. Rees J. Mixing of particulate solids to ensure homogeneity of dosage forms: Need for a critical approach to pharmaceutical process development. Boll Chim Farm 1977;116:445-462